Opportunity Information: Apply for PAR 11 108

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Centers for AIDS Research and Developmental Centers for AIDS Research (P30)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.396 Cancer Biology Research 93.839 Blood Diseases and Resources Research 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research 93.865 Child Health and Human Development Extramural Research 93.989 International Research and Research Training.
  • This funding opportunity was created on Feb 9, 2011 and posted on Feb 9, 2011.
  • Applicants must submit their applications by Jun 14, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education For profit organizations other than small businesses Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Special district governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Small businesses Private institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 11 108

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Centers for AIDS Research and Developmental Centers for AIDS Research (P30) funding opportunity (PAR 11-108) is a National Institutes of Health (NIH) grant program designed to strengthen and accelerate HIV/AIDS research by supporting centralized, shared infrastructure rather than funding only individual research projects. The goal is to build or enhance an institutional "home base" for HIV research that provides administrative leadership and shared scientific resources (often called cores) that investigators can use across multiple studies. By paying for the kinds of expertise, facilities, and coordinated services that are difficult to sustain through traditional single-project grants, the program aims to make HIV research efforts more efficient, collaborative, and impactful.

This opportunity solicits two related types of center awards. Standard Centers for AIDS Research (CFARs) are established, full centers that provide robust shared support for a broad HIV/AIDS research community, typically at a university or a consortium of collaborating institutions. Developmental CFARs (D CFARs) are intended for institutions or regions where HIV research capacity is emerging or expanding; they provide similar shared support but with an additional, explicit purpose: helping investigators and institutions build the track record, organization, and research base needed to compete successfully for a future standard CFAR. In other words, a D CFAR functions as a structured stepping-stone, helping create the governance, cores, collaborations, and scientific productivity that would justify a full CFAR.

A central theme of the program is interdisciplinary and translational collaboration. NIH emphasizes work that connects basic science and clinical investigation, supporting a two-way pipeline between laboratory discoveries and patient- or community-focused studies. The expectation is that CFAR-supported infrastructure will make it easier for basic and clinical researchers to share tools, data, specimens, methods, and expertise, thereby speeding the movement of promising findings into real-world applications. The FOA also highlights the importance of including prevention and behavioral change research, reflecting the reality that effective HIV control depends not only on biomedical advances but also on interventions that address behavior, implementation, and public health practice.

The program further stresses inclusive participation and workforce development in the HIV research enterprise. Applications are expected to broaden engagement of investigators from diverse backgrounds and to cultivate a research environment where new investigators can gain access to shared resources, mentorship, and collaborative networks. By lowering barriers to entry (for example, by providing access to specialized assays, clinical cohorts, biostatistics, regulatory support, or community engagement infrastructure), CFARs are meant to help investigators who might otherwise lack the institutional support needed to compete and contribute.

From an administrative standpoint, this is a discretionary grant mechanism under the P30 center support structure. The award is focused on administrative and shared research support, meaning the center typically coordinates governance, resource allocation, and shared facilities that benefit multiple HIV-related projects. The funding instrument is a grant, and the opportunity does not require cost sharing or matching funds. While the specific scientific cores can vary by institution, the defining feature is that the center provides resources and services "not readily obtained otherwise" through more conventional funding mechanisms, such as standalone R-series research project grants.

Eligibility is broad and includes many types of domestic organizations and governments. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with or without 501(c)(3) status, other than institutions of higher education), for-profit organizations other than small businesses, and small businesses. A wide range of governmental entities may apply as well, including state governments, county governments, city or township governments, special district governments, and independent school districts. The FOA also explicitly recognizes a range of mission-focused and community-rooted entities as eligible where applicable, including faith-based or community-based organizations, Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments), regional organizations, and U.S. territories or possessions. This breadth aligns with the program's interest in expanding and diversifying HIV research capacity and ensuring that strong HIV research infrastructure can be developed in varied settings.

Key administrative details in the source information include the funding opportunity number PAR 11-108 and the title "Centers for AIDS Research and Developmental Centers for AIDS Research (P30)." The opportunity was posted on February 9, 2011, with an original and current closing date of June 14, 2013, and it was archived on July 15, 2013. The listed CFDA program numbers span multiple NIH research domains that intersect with HIV/AIDS, including mental health, drug abuse and addiction, cancer-related research, blood diseases, allergy and immunology/transplantation, microbiology and infectious diseases, child health and human development, and international research and research training. That spread reflects how HIV research often crosses disciplinary boundaries, involving comorbidities, co-infections, oncology, substance use, immune function, and global health.

For applicants or institutions that were preparing a submission during the active period of the FOA, the official announcement was available through the NIH Grants Guide at the provided link (http://grants.nih.gov/grants/guide/pa-files/PAR-11-108.html). For access or technical issues, the contact point listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, which is the general support channel for problems accessing or linking to the full announcement.

Frequently Asked Questions (FAQs)

What is PAR 11-108?

PAR 11-108 is the NIH funding opportunity announcement titled "Centers for AIDS Research and Developmental Centers for AIDS Research (P30)." It supports institutional HIV/AIDS research infrastructure through the P30 center grant mechanism.

What is the overall purpose of the CFAR and Developmental CFAR (P30) program?

The program is designed to strengthen and accelerate HIV/AIDS research by funding centralized, shared infrastructure (for example, leadership, governance, and shared scientific resources) rather than focusing only on individual research projects. The intent is to create or enhance an institutional "home base" that makes HIV research more efficient, collaborative, and impactful.

What does this funding support: individual research projects or shared infrastructure?

This opportunity supports administrative and shared research support infrastructure (often organized as cores and coordinated services). It is not described as a program that primarily funds standalone, individual research projects; instead, it funds resources and services that can be used across multiple HIV-related studies.

What is a CFAR (Centers for AIDS Research) in this program?

A standard CFAR is an established, full center award intended to provide robust shared support for a broad HIV/AIDS research community, typically based at a university or a consortium of collaborating institutions.

What is a Developmental CFAR (D CFAR), and how is it different from a standard CFAR?

A Developmental CFAR is intended for institutions or regions where HIV research capacity is emerging or expanding. It provides shared support similar to a CFAR, but with an added, explicit purpose: helping investigators and institutions build the organization, track record, collaborations, cores, governance, and scientific productivity needed to compete for a future standard CFAR. It functions as a structured stepping-stone toward a full CFAR.

What kinds of shared resources or services might a CFAR provide?

The opportunity describes shared scientific resources ("cores") and coordinated services that investigators can use across multiple studies. Examples mentioned include access to specialized assays, clinical cohorts, biostatistics, regulatory support, and community engagement infrastructure, as well as the broader ability to share tools, data, specimens, methods, and expertise.

Why does NIH emphasize centralized shared infrastructure for HIV research?

The program aims to pay for expertise, facilities, and coordinated services that are difficult to sustain through traditional single-project grants. By doing so, it reduces duplication, improves efficiency, enables collaboration, and helps move research findings more quickly toward real-world applications.

What is meant by an institutional "home base" for HIV research?

In this context, a "home base" refers to a coordinated center structure that provides administrative leadership and shared scientific resources for HIV/AIDS investigators. It is meant to serve as a stable hub that multiple projects and investigators can rely on for services and infrastructure.

What is the grant mechanism used for this opportunity?

This is a discretionary NIH grant under the P30 center support structure. The focus is on center-level administration and shared research support rather than only supporting single, independent projects.

Does this opportunity require cost sharing or matching funds?

No. The provided information states that the opportunity does not require cost sharing or matching funds.

What scientific approach or collaboration model does NIH emphasize for CFARs?

A central theme is interdisciplinary and translational collaboration, with an emphasis on linking basic science and clinical investigation through a two-way pipeline. The goal is to make it easier for researchers to share tools, data, specimens, methods, and expertise to speed the movement of discoveries into practical applications.

Does the program include prevention or behavioral research, or is it strictly biomedical?

The opportunity explicitly highlights the importance of including prevention and behavioral change research. It reflects the view that HIV control depends on both biomedical advances and interventions addressing behavior, implementation, and public health practice.

How does the program support new investigators and workforce development?

The program stresses inclusive participation and workforce development. Applications are expected to broaden engagement of investigators from diverse backgrounds and cultivate an environment where new investigators can access shared resources, mentorship, and collaborative networks, helping lower barriers to entry for investigators who may lack specialized institutional support.

What types of organizations are eligible to apply?

Eligibility is broad and includes many domestic organizations and government entities. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education), for-profit organizations other than small businesses, and small businesses.

Are governmental entities eligible applicants?

Yes. The listed eligible governmental applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.

Are community-rooted and mission-focused organizations explicitly recognized as eligible?

Yes. The eligibility list explicitly recognizes faith-based or community-based organizations and several institution types such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments), regional organizations, and U.S. territories or possessions.

Is the opportunity limited to universities, or can consortia apply?

The description notes that standard CFARs are typically at a university or a consortium of collaborating institutions, indicating that consortium-based approaches are consistent with how CFARs are commonly structured.

What does "resources not readily obtained otherwise" mean in this context?

It refers to shared resources and services that are difficult to sustain or access through conventional, standalone research project mechanisms (such as R-series grants). The CFAR model is meant to provide centralized capabilities that many projects can use, rather than each project trying to build the same capacity independently.

When was PAR 11-108 posted, and what were the closing dates?

The opportunity was posted on February 9, 2011. The original and current closing date listed is June 14, 2013. It was archived on July 15, 2013.

Is this funding opportunity still active?

No. Based on the provided administrative details, it has a closing date of June 14, 2013 and was archived on July 15, 2013.

Where can applicants find the official NIH announcement for PAR 11-108?

The official announcement is available through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PAR-11-108.html

Who should be contacted for access or technical issues with the announcement link?

The contact listed for access or technical issues is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

What NIH/CFDA areas are associated with this opportunity?

The CFDA program numbers listed span multiple NIH research domains that intersect with HIV/AIDS, including mental health; drug abuse and addiction; cancer-related research; blood diseases; allergy and immunology/transplantation; microbiology and infectious diseases; child health and human development; and international research and research training.

Why does the opportunity span so many research domains?

The description notes that HIV research often crosses disciplinary boundaries, including comorbidities, co-infections, oncology, substance use, immune function, and global health. The broad CFDA coverage reflects that cross-cutting nature.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Office of Elementary and Secondary Education (OESE) Native Hawaiian Education Program CFDA Number 84.362A

Previous opportunity: Engaging Local Indigenous Organizations in the Implementation and Provision of Comprehensive HIV Care, Treatment, and Prevention Services in Six States of the Federal Republic of Nigeria under the President s Emergency Plan for AIDS Relief (PEPFAR)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 11 108

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 11 108) also looked into and applied for these:

Funding Opportunity
Grand Opportunity in Medications Development for Substance Related Disorders (U01) Apply for PAR 11 109

Funding Number: PAR 11 109
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 11 111

Funding Number: PA 11 111
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 11 117

Funding Number: PAR 11 117
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Specific pathogen free macaque colonies (U42) Apply for PAR 11 116

Funding Number: PAR 11 116
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Specific pathogen free macaque colonies (U24) Apply for PAR 11 115

Funding Number: PAR 11 115
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV/AIDS Implementation Science Targeting Drug Using Populations A Collaboration with PEPFAR (R01) Apply for RFA DA 12 002

Funding Number: RFA DA 12 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Placebo Effect Mechanisms and Methodology (R21) Apply for RFA DA 12 004

Funding Number: RFA DA 12 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Placebo Effect Mechanisms and Methodology (R01) Apply for RFA DA 12 003

Funding Number: RFA DA 12 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Childhood Cancer Survivor Study (CCSS)(Limited Competition U24) Apply for RFA CA 11 501

Funding Number: RFA CA 11 501
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medication Initiative for Tobacco Dependence (MITD) A New Product Development Partnership (PDP)(UH2/UH3) Apply for RFA DA 11 015

Funding Number: RFA DA 11 015
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research Centers in Minority Institutions Program (G12) Apply for PAR 11 132

Funding Number: PAR 11 132
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NLM Institutional Training Grants for Research Training in Biomedical Informatics (T 15) Apply for RFA LM 11 001

Funding Number: RFA LM 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition National Primate Research Centers (P51) Apply for PAR 11 136

Funding Number: PAR 11 136
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 11 001

Funding Number: RFA EB 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 11 150

Funding Number: PAR 11 150
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 11 151

Funding Number: PAR 11 151
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $680,000
The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 11 152

Funding Number: PAR 11 152
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 11 156

Funding Number: PAR 11 156
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 11 146

Funding Number: PAR 11 146
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) Apply for RFA DA 12 006

Funding Number: RFA DA 12 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 108", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.